University Of Southern California
Clinical trials sponsored by University Of Southern California, explained in plain language.
-
Pre-Surgery drug cocktail aims to wipe out rectal cancer
Disease control TerminatedThis trial investigates whether giving a combination of bevacizumab (a drug that blocks blood vessel growth to tumors) and chemotherapy before surgery can eliminate all signs of cancer in people with stage II or III rectal cancer. Participants receive the treatment before their p…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Experimental combo for resistant leukemia shows early promise but trial halted
Disease control TerminatedThis pilot study tested a new drug called sEphB4-HSA combined with standard chemotherapy (azacitidine or decitabine) in 7 patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia that had returned or not responded to prior treatment. The …
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Experimental combo for tough prostate cancer shows early promise but trial halted
Disease control TerminatedThis study tested a combination of two drugs, bortezomib and docetaxel, in 15 men with advanced prostate cancer that had stopped responding to hormone therapy. The goal was to see if the combo could lower PSA levels and ease pain. The trial was terminated early, so the findings a…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Shoulder surgery recovery: steroid trial halted after just 4 patients
Disease control TerminatedThis study tested whether taking the steroid oxandrolone for 12 weeks after rotator cuff repair could improve tendon healing and muscle mass. Only 4 people participated before the trial was stopped early. Because it was so small, we cannot draw any reliable conclusions about whet…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Experimental combo shot for pancreatic cancer stalls after just 2 patients
Disease control TerminatedThis very early trial tested two immune-stimulating drugs injected directly into tumors for people with stage IV pancreatic cancer. The goal was to see if the combination could shrink tumors or slow their growth. However, the study was stopped early after enrolling only 2 partici…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Kidney transplant study tests Once-Daily pill to replace Twice-Daily dosing
Disease control TerminatedThis study tested whether a once-daily extended-release form of tacrolimus (Envarsus XR) combined with azathioprine could work as well as the standard twice-daily tacrolimus plus mycophenolate in preventing kidney transplant rejection. The trial planned to enroll 20 adults receiv…
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
One-Time radiation during breast surgery: can imaging pick the right patients?
Disease control TerminatedThis study looked at whether mammography and breast MRI could help identify patients with early-stage breast cancer (DCIS) who could safely receive a single dose of radiation during surgery, instead of weeks of daily radiation afterward. The goal was to avoid repeat surgeries and…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Bladder cancer drug combo trial stalls early
Disease control TerminatedThis small phase II study tested whether combining the chemotherapy drug docetaxel with the targeted therapy lapatinib could help patients with advanced bladder cancer that had already been treated with platinum-based chemo. Only 15 people enrolled before the study was terminated…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Exercise program targets metabolic risks in cancer survivors
Disease control TerminatedThis study looked at whether a specific type of exercise, combining aerobic and resistance training in short bursts, could improve metabolic health in overweight or obese breast and prostate cancer survivors who had finished treatment. The goal was to reduce insulin resistance an…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Blood test may spot lung cancer without a needle biopsy
Diagnosis TerminatedThis study looked at whether a blood test (called a fluid biopsy) could help diagnose lung cancer. Researchers collected blood samples from 51 people who were either scheduled for a lung biopsy or had recently had one. The goal was to see if the blood test could accurately detect…
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Jun 26, 2026 13:46 UTC
-
Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short
Symptom relief TerminatedThis pilot study aimed to compare trazodone and quetiapine for treating delirium in ICU patients. It enrolled only 10 adults in the surgical ICU who had delirium with symptoms like agitation or hallucinations. The study was terminated early, so the results are very limited and ca…
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can bringing palliative care home ease suffering?
Symptom relief TerminatedThis study tested whether providing palliative care at home, through a team of doctors, nurses, social workers, and chaplains, could improve symptoms and quality of life for people with advanced cancer, heart failure, or COPD. The plan was to enroll over 1,100 patients, but the t…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Fitness trackers vs. Doctor's eye: which better gauges cancer Patients' mobility?
Knowledge-focused TerminatedThis study tested whether consumer movement trackers could provide a more precise measure of cancer patients' physical abilities than the standard ECOG score, which relies on a doctor's observation. Researchers enrolled 41 cancer patients and used a Kinect device to record their …
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Tiny cancer study halted after just one patient
Knowledge-focused TerminatedThis early-phase trial aimed to see how a new version of the chemotherapy drug paclitaxel, called FID-007, affects immune cells in head and neck cancer tumors. Researchers planned to study tumor samples before and after treatment in people scheduled for surgery. However, the stud…
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:26 UTC
-
Fitbits could predict cancer trial side effects
Knowledge-focused TerminatedThis study tested whether wearable fitness trackers (like Fitbits) and smartphone diaries can give a more accurate picture of cancer patients' physical function than standard doctor assessments. Researchers enrolled 31 cancer patients starting early-phase clinical trials. The goa…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:54 UTC